| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | Our data highlighted the molecular aetiology and clinical significance of RIPK4 in BC: upregulation of RIPK4 contributes to NF-κB activation, and upregulates VEGF-A, and BC progression. | 29867225 | 2018 | ||||
|
0.080 | Biomarker | disease | BEFREE | Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer. | 26798188 | 2015 | ||||
|
0.080 | Biomarker | disease | BEFREE | Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma. | 26129954 | 2015 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | The positive expression rates of survivin and VEGF in superficial BTCC were 66.7% (52/78) and 69.2% (54/78), respectively, which were significantly higher than those in the control group, 0% (0/10). | 23613251 | 2013 | ||||
|
0.080 | Biomarker | disease | BEFREE | Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker. | 18513850 | 2009 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder. | 18645275 | 2008 | ||||
|
0.080 | Biomarker | disease | BEFREE | Over expression of matrix metalloproteinase-1 and 12, transforming growth factor-beta1, vascular endothelial growth factor and fos may be associated with the recurrence of superficial low grade bladder transitional cell carcinoma. | 17296440 | 2007 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | As C-erbB-2 oncoprotein and vascular endothelial growth factor (VEGF) have been shown to be over-expressed in TCC of the bladder, it has been postulated that they may be important in its pathogenesis.The purpose of this study was to 1.) differentially evaluate the effect of BCG immunotherapy in treated and untreated cohorts on the immunohistochemical expression of C-erbB-2 and VEGF in formalin-fixed paraffin-embedded sections of superficial and superficially invasive (Stage Ta-T1) transitional cell carcinoma of the bladder. | 12474525 | 2002 |